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Introduction 
Annular elastolytic giant cell granuloma (AEGCG) is a rare 
granulomatous dermatosis of controversial origin characterized by 
loss of elastic fibers and elastophagocytosis by multinucleated 
giant cells [1]. Lesions of AEGCG are usually located on sun-
exposed areas [2]. We present two patients with AEGCG both 
involving sun-exposed and covered areas. 
 
Case reports 
 
  
Figure 1 Figure 2 
Figure 1. Annular red plaques localized on the lateral aspect of her right 
forearm (patient 1) 
 
Figure 2. Annular red plaques localized on the upper back (patient 2) 
A 66-year-old woman (patient 1) and a 70-year-old man 
(patient 2) presented with a slightly pruritic skin eruption evolving 
for 2 years and 3 months, respectively. They were not taking any 
medication. There was no family history of skin disorders. Physical 
examination revealed symmetric, erythematous papules and 
plaques, sometimes with annular configuration, with central 
atrophy and raised erythematous margins on the upper back, 
forearms, dorsal hands, and lower extremities (Figures 1 and 2). 
There was no mucous membrane or nail involvement. We 
performed a skin biopsy from the two patients. Histopathologic 
findings were almost identical. Both showed granulomatous 
infiltrates in the dermis consisting primarily of multinucleated giant 
cells, some of which contained fragments of elastic tissue 
(elastophagocytosis), and loss of elastic fibers in the center of the 
lesion (Figures 3 and 4). Laboratory tests including complete blood 
cell count, chemistry panel, antinuclear antibody, urinalysis, and 
chest x-ray were within normal limits. 
 
  
Figure 3 Figure 4 
Figure 3. Granulomatous infiltrates in the dermis (H&E, x40) 
 
Figure 4. Phagocytosis of elastic fibers by multinucleated giant cells 
(H&E, x100) 
The patient’s response to the treatment was different. The 
female patient was treated with topical betamethasone dipropionate 
cream for 3 weeks with complete regression of the lesions. The 
male patient failed to respond to topical corticosteroids and PUVA 
therapy. Then, he was treated with hydroxychloroquine 400 
mg/day over a period of 4 months with a good clinical result. 
However, the treatment had to be stopped because of early findings 
of retinopathy. Treatment with cyclosporine 200 mg/day was 
started with a complete response after 7 months. Eighteen months 
after discontinuance of the treatment there is no clinical recurrence 
of the lesions. 
 
Discussion 
In 1975 O’Brien described a new type of annular skin lesion 
with elastolysis and elastophagocytosis, localized on light-exposed 
body areas and titled this entity actinic granuloma [2, 3]. The term 
AEGCG was proposed by Hanke et al. in 1979 and includes the 
lesions previously called actinic granuloma, atypical necrobiosis 
lipoidica, and Miescher’s granuloma [2, 3, 4]. They defend the 
observation that solar elastosis is not always present; although less 
common, the lesions could be present in covered areas. 
Annular elastolytic giant cell granuloma is an uncommon 
disease that predominantly affects older adults, with no sex 
predilection [2]. Clinically, red papules and hypochromic or 
atrophic plaques with elevated borders and central depression are 
typically located on sun-exposed skin. There have been reports of 
lesions located on sun-protected sites [5], as in our case. There 
have also been generalized forms reported with red asymptomatic 
papules [6]. 
The histopathologic features are best demonstrated by a 
biopsy of the elevated edge of the plaque [7]. They are 
characterized by granulomatous infiltrates with multinucleated 
giant cells in the upper and mid dermis, loss and fragmentation of 
elastic fibers, and elastophagocytosis by giant cells, without 
necrobiosis and mucin deposition [2, 7, 8]. These features help to 
distinguish AEGCG from granuloma annulare and necrobiosis 
lipoidica, which are the main disorders in the histological 
differential diagnosis [7]. It is speculated that solar radiation, heat 
or other unknown factors transform the antigenicity of the elastic 
fibers and induce the cellular immunological reaction [1, 2,9]. 
Immunohistochemical studies showing that CD4+ cells 
predominated over CD8+ cells in the inflammatory infiltrate also 
support this theory [1,2]. It has been also proposed that diabetes 
mellitus could be implicated in the etiology by producing structural 
damage of the elastic tissue [2]. There have been reported cases of 
AEGCG associated with systemic sarcoidosis, cutaneous 
amyloidosis, molluscum contagiosum, squamous cell carcinoma of 
the lung and cutaneous T-cell lymphoma [2]. 
The treatment for AEGCG remains a challenge. Variable 
results have been reported with therapies such as topical or 
intralesional steroids, cryotherapy, clofazimine, antimalarials 
(chloroquine and hydroxychloroquine), dapsone, PUVA, and 
cyclosporine [1, 9]. Some cases resolve spontaneously [8, 9]. 
Although our patients were similar clinically, they responded very 
differently to therapy. 
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